Embed Size (px)
Citation preview
References
1. Abbas and Lichtman A.H. (2009) : "Ch.2 Innate Immunity". Basic
Immunology. Functions and disorders of the immune system (3rd ed.).
2. Abbas and Lichtman A.H. (2009) : Basic immunology-Chapter one
3rd
ed , introduction to immune system pp 1-23.
3. Abbas and Lichtman A.H. (2009) : Basic immunology-Chapter three
3rd
ed , function and disorders of the immune system, pp 45-67.
4. Adamantiades (1930) : Hulusi Behçet Medical Society of Athens;
586-93.
5. Adams A and Lehman TJ (2005) : Update on the pathogenesis and
treatment of systemic onset juvenile rheumatoid arthritis. Curr Opin
Rheumatol. Sep; 17 (5): 612-6.
6. Aderem A. and Ulevitch R.J (2000) : Nature 406: 782.
7. Aderem Alan, Underhill and David (1999) : "Mechanisms of
Phagocytosis in Macrophages". Annual Review of Immunology 17:
593–623.
8. Adler A.J. et al., (1998) : J. Exp. Med. 187:1555.
9. Admou B (2009) : Ann Biol Clin (Paris). May-Jun.
10. Agata Y. et al., (1996) : Int. Immunol. 8:765.
11. Aglas F, Hermann J, and Egger G (1998) : Abnormal directed
migration of blood polymorphonuclear leukocytes in rheumatoid
arthritis. Potential role in increased susceptibility to bacterial infections.
Mediators Inflamm, 7:19-23.
12. Aicher A. et al., (2000) : J. Immunol. 164:4689.
13. Ainsworth and Claire (2003) : The stranger within (subscription).
"New Scientist", Nov. 15, 356 (6): 580–92.
14. Ainsworth and Claire (2003) : "pregnancy may induce
autoimmunity" Nature Reviews Immunology; 6 (5): 394–403.
15. Akiko Iwasaki and Ruslan Medzhitov (2010) : Regulation of
Adaptive Immunity by the Innate Immune System; Vol. 327. no. 5963,
pp. 291-295.
16. Alan J. Lerner, (2006) : Diagnostic Criteria in Neurology, edited by
17. Alberts Bruce, Alexander Johnson, Julian Lewis, Martin Raff,
Keith Roberts, and Peter Walters (2002) : Molecular Biology of the
Cell; Fourth Edition. New York and London; Garland Science.
18. Alimonti JB, Ball TB and Fowke KR (2003) : "Mechanism of
CD4+ T lymphocyte cell death in human immunodeficiency virus
infection and AIDS.". J. Gen. Virol. 84 (7): 1649–1661.
19. Alvarez-Lafuente R, Fernández-Gutiérrez B, de Miguel S, et al.,
(2005) : "Potential relationship between herpes viruses and rheumatoid
arthritis: analysis with quantitative real time polymerase chain
reaction". Ann. Rheum. Dis. September 64 (9): 1357–9
20. Anisur Rahman and David A (2008) : "Review Article: Systemic
Lupus Erythematosus" . Isenberg ,N Engl J Med Feb28; 358 (9): 929–
939.
21. Anwar Al Hammadi (2010) : http//emedicin.medscape.com/
article/331037.
22. Arcus VL, Proft T, Sigrell JA, Baker HM, Fraser JD, and Baker
EN (2000) : Conservation and variation in superantigen structure and
activity highlighted by the three-dimensional structures of two new
superantigens from Streptococcus pyogenes. J. Mol. Biol. May, 299
(1): 157–68.
23. Artlett CM, Smith JB, and Jimenez SA (1999) : New perspectives
on the etiology of systemic sclerosis. Mol Med Today. Feb;5 (2): 74-8.
24. Asano M et al., (1996) : J. Exp. Med. 184: 387.
25. Atagunduz P, Appel H, Kuon W, Wu P, Thiel A, Kloetzel PM, et
al., (2005) : HLA-B27-restricted CD8+ T cell response to cartilage-
derived self peptides in ankylosing spondylitis. Arthritis Rheum 52:
892-901.
26. Atkinson JP (1986) : Complement activation and complement
receptors in systemic lupus erythematosus. Springer Semin
Immunopathol; 9: 179–94.
27. Augusto C Posadas (2009) : http://www.britannica.com/EB checked/
topic/623748/vasculitis
28. Avouac J, Gossec L, and Dougados M (2006) : "Diagnostic and
predictive value of anti-cyclic citrullinated protein antibodies in
rheumatoid arthritis: a systematic literature review". Ann. Rheum. Dis.
July, 65 (7): 845–51.
29. Avouac J, Vicaut E, Bardin T, Richette P (2010) : Efficacy of joint
lavage in knee osteoarthritis: meta-analysis of randomized controlled
studies. Rheumatology (Oxford). Feb;49(2): 334-40.
30. Aw D, Silva AB and Palmer DB (2007) : "Immunosenesc -ence:
emerging challenges for an ageing population", Immunology April, 120
(4): 435–46.
31. Bang H, Egerer K, Gauliard A, et al. (2007) : "Mutation and
citrullination modifies vimentin to a novel autoantigen for rheumatoid
arthritis". Arthritis Rheum. August 56 (8): 2503–11.
32. Barclay A.N, van Beek E.M, Cochrane F, and van den Berg T.K,
(2005) : "Membrane proteins with immunoglobulin-like domains-a
master superfamily of interaction molecules". Semin Immunol 15 (4):
215–23.
33. Beier K.C et al., (2000) : Eur. J. Immunol. 30:3707.
34. Belov, Katherine, Janine E. Deakin, Anthony T. Papenfuss, et al.,
(2006) : "Reconstructing an Ancestral Mammalian Immune
Supercomplex from a Marsupial Major Histocompatibility Complex".
PLoS Biol 4(3) (e46): e46.
35. Bennouna S and Denkers EY (2005) : Microbial antigen triggers
rapid mobilization of TNF-alpha to the surface of mouse neutrophils
transforming them into inducers of high-level dendritic cell TNF-alpha
production. J Immunol, 174:4845-4851.
36. Bergman Y and Cedar H (2004) : "A stepwise epigenetic process
controls immunoglobulin ". Nat Rev Immunol 4 (10): 753–61.
37. Bianchi M.E and Agresti A (2005) : HMG proteins; dynamic players
in gene regulation and differentiation. Curr. Opin. Genet. Dev. 15: 496–
506.
38. Binns C (2006) : Natural Body Guards How Your Killer Cells Get
Motivated. Livescience.com. Retrieved on 2007-10-20.
39. Biron P, Montpetit P, Infante-Rivard C and Lery L. (1988) :
Myasthenia gravis after general anethesia and hepatitis B vaccine. Arch
Intern Medicine;148: 2685.
40. Boghog (2008) : http://en.wikipedia.org en.wikipedia
41. Bonilla FA, Bernstein IL, Khan DA, et al., (2005) : Practice
parameter for the diagnosis and management of primary
immunodeficiency. Ann Allergy Asthma Immunol.;94: S1-S63.
42. Borghesi L and Milcarek C (2006) : "From B cell to plasma cell:
regulation of V(D)J recombination and antibody secretion". Immunol
Res 36 (1-3): 27–32.
43. Bostan M, Constantin MC, Nicolau A, Hirt M, Galatiuc C, Matei
I, Brasoveanu LI, and Iordachescu D (2002) : Study of chemotactic
activity developed by neutrophils from rheumatoid arthritis patients.
Rom Arch Microbiol Immunol , 61: 243-258.
44. Bottley G, Watherston O, Hiew Y, Norrild B, Cook G and Blair G
(2007) : "High-risk human papillomavirus E7 expression reduces cell-
surface MHC class I molecules and increases susceptibility to natural
killer cells". Oncogene.
45. Bowers and William (2006) : "Immunology-Chapter nine; Cells
involved in immune responses". Microbiology and Immunology On-
Line Textbook. USC School of Medicine.
46. Bowers and William (2006) : "Immunology-Chapter Thirteen;
Immunoregulation". Microbiology and Immunology On-Line
Textbook. USC School of Medicine.
47. Brandt KD, (1974) : Enhanced extractability of articular cartilage
protoglycans in osteoarthrosis. Biochem J; 143:475.
48. Brennan P and Kendrick K (2006) : "Mammalian social odours:
attraction and individual recognition". Philos Trans R Soc Lond B Biol
Sci. 361 (1476): 2061-78.
49. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, and
Treacher DF (2006) : Neutrophils in development of multiple organ
failure in sepsis. Lancet, 368: 157-169.
50. Brüne B (2003) : "Nitric oxide; NO apoptosis or turning it ON?". Cell
Death Differ. August 10 (8): 864–9.
51. Buch T. et al., (2002) : Immunity 16: 707.
52. Buonpane RA, Moza B, Sundberg EJ and Kranz DM (2005) :
"Characterization of T cell receptors engineered for high affinity
against toxic shock syndrome toxin-1". J. Mol. Biol. October, 353 (2):
308–21.
53. Burnet F, (1957) : A modification of Jerne's theory of antibody
production using the concept of clonal selection. Aust J Sci 20: 67–69.
54. Buyon JP and Clancy RM (2003) : "Maternal autoantibodies and
congenital heart block: mediators, markers, and therapeutic approach".
Semin. Arthritis Rheum. December 33 (3): 140–54.
55. Calame KL, (2001) : Nat. Immunol. 2:1103.
56. Cannon JG, (2000) : "Inflammatory Cytokines in Nonpathological
States". News Physiol Sci. 15: 298–303.
57. Carding S.R and P.J Egan (2002) : Nat. Rev. Immunol. 2:336.
58. Carlos J Lozada and Eli Steigelfest (2010) : http//emedicin.
Medscape.com/article/33147
59. Carlos J Lozada, (2010) : http//emedicin.medscape.com/
article/33147
60. Carlson JA, Cavaliere LF, Grant-Kels JM (2006) : Cutaneous
vasculitis ; diagnosis and management. Clin Dermatol. Sep-Oct; 24 (5):
414-29.
61. Carp HJA, Meroni PL and Shoenfeld Y (2008) : Autoantibodies as
predictors of pregnancy complications. Rheumatology 47(Suppl 3):
iii6–8.
62. Carroll MC, (1998) : The role of complement and complement
receptors in the regulation of immunity. Ann Rev Immunol, 16: 545-
568.
63. Carter JD and Hudson AP (2009) : reactive arthritis: clinical aspects
and medical management. Rheum Dis Clin North Am. Feb; 35 (1): 21-
44.
64. Carter JD, Valeriano J, Vasey FB (2004) : Doxycycline versus
doxycycline and rifampin in undifferentiated spondyloarthropathy, with
special reference to chlamydia-induced arthritis. A prospective,
randomized 9-month comparison. J Rheumatol. Oct; 31(10): 1973-80.
65. Casali P and Zan H (2004) : "Class switching and Myc translocation:
how does DNA break?". Nat. Immunol. 5 (11): 1101–3.
66. Castelino M and Barton A (2010) : Curr Opin Rheumatol. Genetic
susceptibility factors for psoriatic arthritis. Mar;22(2): 152-6.
67. Ceredig R et al., (2000) : Eur. J. Immunol. 30:759.
68. Cervera R, Khamashta MA, Font J, et al., (2005) : Systemic lupus
erythematosus: clinical and immunologic patterns of disease expression
in a cohort of 1,000 patients. The European Working Party on Systemic
Lupus Erythematosus. Medicine (Baltimore); 72: 113–24.
69. Chandra, J, Wiedmer, T, Sims, PJ, Henter, JI, Orrenius, S and
Samali, A (1999) : malnutrition is the most common cause of
immunodeficiency, Biophys. Res. Commun; 266 (2): 504-11.
70. Chapoval A. et al., (2001) : Nat. Immunol. 2: 269.
71. Chen G, Goeddel DV (2002) : "TNF-R1 signaling: a beautiful
pathway". Science 296 (5573): 1634–5.
72. Chen HA, Lin KC, Chen CH, et al., (2005) : The effect of etanercept
on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in
patients with rheumatoid arthritis. Ann Rheum Dis. Jan; 65(1): 35-9.
73. Chen K, Xu W, Wilson M, He B, Miller NW, Bengtén E, Edholm
ES, Santini PA, Rath P, Chiu A, Cattalini M, Litzman J, B Bussel
J, Huang B, Meini A, Riesbeck K, Cunningham-Rundles C, Plebani
A and Cerutti A (2009) : "Immunoglobulin D enhances immune
surveillance by activating antimicrobial, proinflammatory and B cell-
stimulating programs in basophils". Nature Immunology 10 (8): 889–
98.
74. Cheng P.C. et al., (1999) : J. Exp. Med. 190:1549.
75. Cherukuri A. et al., (2001) : Immunity 14:169.
76. Chiarugi A, Moskowitz MA (2002) : "PARP-1—a perpetrator of
apoptotic cell death?". Science 297 (5579): 259–63.
77. Christopher Sjöwall, Anders A Bengtsson, Gunnar Sturfelt and
Thomas Skogh (2004) : Arthritis Res Ther, 6:R87-R94.
78. Coenen D, Verschueren P, Westhovens R, Bossuyt X (2007) :
"Technical and diagnostic performance of 6 assays for the
measurement of citrullinated protein/peptide antibodies in the diagnosis
of rheumatoid arthritis". Clin. Chem. 53 (3): 498–504.
79. Coornaert B, Carpentier I and Beyaert R (2009) : The transcription
factor NF-kappaB in inflammation and immunity; May Nature.
4;459(7247): 712-6.
80. Coornaert B, Carpentier I, and Beyaert R (2009) : inappropriate
functioning of the immune system is linked to immune disorders Nat.
Immunol. 4;459:712(6).
81. Coornaert B, Vincent J, Carpentier I, et al., (2009) : "Apoptosis is
an active process." Int. Immunol. 8:765.
82. Cotran; Kumar, Collins (1998) : Robbins Pathologic Basis of
Disease. Philadelphia: W.B Saunders Company.
83. Coyle A.J. et al., (2000) : Immunity 13:95.
84. Cream JJ, Leven GM, and Canan CD (1971) : Erythema elevatum
diutinum. Br J Dermatol; 84: 393-9.
85. Cutolo M, Capellino S and Straub RH (2008) : Oestrogens in
rheumatic diseases:friend or foe? Rheumatology 47(Suppl 3): iii2–5.
86. Dadi HK, Simon AJ and Roifman CM (2003) : Effect of maturation
on alpha/beta and gamma/delta T-cell lineages in severe combined
immunodeficiency. N Engl J Med. Nov 6;349 (19):1821-8.
87. Dana Jacobs-Kosmin, (2010) : http://www.britannica.com/
EBchecked/ topic/623748/vasculitis
88. Daniel Ricklin and John D Lambris (2007) : Nature Biotechnology
25, 1265 - 1275 Complement-targeted therapeutics.
89. David F, Farley J, Huang H, Lavoie JP and Laverty S (2007) :
Cytokine and chemokine gene expression of IL-1beta stimulated equine
articular chondrocytes. Vet Surg. Apr; 36(3): 221-7. Erratum in: Vet
Surg. Jul; 37(5): 499.
90. David, Male, Roitt I et al., (2006) : J Immunology (7th ed) London;
Mosby.
91. Davidson A and Diamond B (2001) : Autoimmune diseases. N Engl
J Med 345: 340–350.
92. Davies DJ, Moran JE, Niall JF and Ryan GB (1982) : Segmental
necrotising glomerulonephritis with antineutrophil antibody; possible
arbovirus aetiology.Brit Med J; 285: 606.
93. D'Cruz D, Chesser AM, Lightowler C, et al., (1995) :
Antineutrophil cytoplasmic antibody-positive crescentic
glomerulonephritis associated with antithyroid drug treatment. Br J
Rheumatol; 34:1090-1.
94. D'Cruz D, Chesser AM, Lightowler C, et al., (1995) : "Drug
induced vasculitis". Br J Rheumatol; 34:1092-3.
95. Dean Laura, (2005) : "Chapter 4: Hemolytic disease of the newborn".
Blood Groups and Red Cell Antigens. NCBI Bethesda (MD): National
Library of Medicine (US).
96. Decker P, (2006) : Nucleosome autoantibodies. Clin. Chim. Acta.
366: 48–60.
97. Dejean LM, Martinez-Caballero S, Manon S, Kinnally KW (2006)
: "Regulation of the mitochondrial apoptosis-induced channel, MAC,
by BCL-2 family proteins". Biochim. Biophys. Acta February 1762 (2):
191–201.
98. Del Rosso A, Generini S, Pignone A, et al., (1999) : Vasculitides
secondary to systemic disease. Clin Dermatol; 17: 533-47.
99. Diane L Kamen, Fredrick M Wigley, and Alan N Brown (2006) : J
Rheumatol; 33:1886–8
100. Dijstelbloem HM, Bijl M, Fijnheer R, et al., (2006) : Fcgamma
receptor polymorphisms in systemic lupus erythematosus: association
with disease and in vivo clearance of immune complexes. Arthritis
Rheum; 43: 2793–800.
101. Direskeneli H, (2001) : Behcet's disease; infectious aetiology, new
autoantigens, and HLA-B51. Ann Rheum Dis. Nov; 60 (11): 996-1002.
102. Doggrell S, (2003) : "Is natalizumab a breakthrough in the treatment
of multiple sclerosis?". Expert Opin Pharmacother 4 (6): 999–1001.
103. Domínguez-López ML, Ortega-Ortega Y, Manríquez-Raya JC,
Burgos-Vargas R, Vega-López A, García-Latorre E (2009) : Clin
Exp Rheumatol. Jul-Aug;27(4): 626-32.
104. Doria A, Bajocchi G, Tonon M, Salvarani C (2008) : Pre-pregnancy
counselling of patients with vasculitis. Rheumatology 47(Suppl 3):
iii13–15.
105. Durandy A (2003) : "Activation-induced cytidine deaminase: a dual
role in class-switch recombination and somatic hypermutation". Eur. J.
Immunol. 33 (8): 2069–73.
106. E.M Tan, P.H Schur, R.I Carr, and H.G Kunkel (1966) :
Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of
patients with systemic lupus erythematosus. J. Clin. Invest. 45:1732–
1740.
107. Edelman GM and Gally JA (1962) : "The nature of Bence-Jones
proteins. Chemical similarities to polypetide chains of myeloma
globulins and normal gamma-globulins". J. Exp. Med. 116: 207–27.
108. Edwards JC and Cambridge G (2006) : "B-cell targeting in
rheumatoid arthritis and other autoimmune diseases.". Nature Reviews
Immunology 6 (5): 394–403.
109. Egan CA, Taylor TB, Meyer LJ, et al., (1999) : IgA1 is the major
IgA subclass in cutaneous blood vessels in Henoch-Schönlein purpura.
Br J Derm;141(5): 859-62.
110. Egger G, Klemt C, Spendel S, Kaulfersch W, and Kenzian H
(1994) : Migratory activity of blood polymorphonuclear leukocytes
during juvenile rheumatoid arthritis, demonstrated with a new whole-
blood membrane filter assay. Inflammation, 18:427-441.
111. El Benna J, Hayem G, Dang PM, Fay M, Chollet-Martin S, Elbim
C, Meyer O, Gougerot-Pocidalo MA (1997) : NADPH oxidase
priming and p47phox phosphorylation in neutrophils from synovial
fluid of patients with rheumatoid arthritis and spondylarthropathy.
Inflammation, 26: 273-278.
112. Eleonora Market and F. Nina Papavasiliou (2003) : V(D)J
Recombination and the Evolution of the Adaptive Immune System,
PLoS Biology1(1); e16.
113. Elkyan O, Yaron M, Caspi D (1999) : Minocycline-induced
autoimmune syndromes; An overview. Sem Arthr Rheum;28(6): 392-7.
114. Emma Farme (2006) : Labelled diagram of a cell undergoing
apoptosis. File adapted from a German Wikipedia entry:
http://de.wikipedia.org/wiki/Bild:Apoptose-german.png
115. Erkan D, Patel S, Nuzzo M, et al., (2008) : Management of the
controversial aspects of the antiphospholipid syndrome pregnancies: a
guide for clinicians and researchers. Rheumatology 47(Suppl 3): iii23–
7.
116. Ethuin F, Gerard B, Benna JE, Boutten A, Gougereot-Pocidalo
MA, Jacob L, Chollet-Martin S (2004) : Human neutrophils produce
interferon gamma upon stimulation by interleukin-12. Lab Invest, 84:
1363-1371.
117. Eustice R (2006) : Autoantibodies, instead of acting against foreign
invaders as normal antib odies do, attack the body's own cells
About.com.arthritis. Proc Natl Acad Sci U S A ; 87: 4111-4114.
118. Evans MJ, MacLaughlin S, Marvin RD, et al., (2006) : Estrogen
decreases in vitro apoptosis of peripheral blood mononuclear cells from
women with normal menstrual cycles and decreases TNF-alpha
production in SLE but not in normal cultures. Clin Immunol
Immunopathol; 82: 258–62.
119. Falk RJ, Terrell RS, Charles LA and Jennette JC (1990) : Anti-
neutrophil cytoplasmic autoantibodies induce neutrophils to
degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U
S A;87: 4115-4119.
120. Fanning LJ, Connor AM and Wu GE (1996) : "Development of the
immunoglobulin repertoire". Clin. Immunol. Immunopathol. 79 (1): 1–
14.
121. Feldmann M and Maini R (2001) : "Anti-TNF alpha therapy of
rheumatoid arthritis: what have we learned?". Annu Rev Immunol 19:
163–96.
122. Ferrell PB, Aitcheson CT, Pearson GR, and Tan EM (1981) :
"Seroepidemiological study of relationships between Epstein-Barr virus
and rheumatoid arthritis" March. J. Clin. Invest. 67 (3): 681–7.
123. Fesik SW, Shi Y. (2001) : "Controlling the caspases". Science 294
(5546): 1477–8.
124. Firestein Gary, Panayi Gabriel, Wollheim Frak (2006) :
Rheumatoid arthritis, (2nd Ed.) 608p.
125. Firestein, Gary S (2005) : Immunologic Mechanisms in the
Pathogenesis of Rheumatoid Arthritis Journal of Clinical
Rheumatology, June vol 11, issue 3, ppS39, S44.
126. Fischbach FT and Dunning MB (2004) : Manual of Laboratory and
Diagnostic Tests, 7th ed. Philadelphia: Lippincott Williams and
Wilkins.
127. Foell D and Roth J (2004) : Proinflammatory S100 proteins in
arthritis and autoimmune disease. Arthritis Rheum, 50: 3762-3771.
128. Font J, Ramos-Casals M, Cervera R, et al., (1998) : Antineutrophil
cytoplasmic antibodies in primary Sjögren's Syndrome: Prevalence and
clinical significance. Br J Rheum;37:1287-91.
129. Franceschini F and Cavazzana I (2005) : "Anti-Ro/SSA and La/SSB
antibodies". Autoimmunity February 38 (1): 55–63.
130. Freeman G.J. et al., (2000) : Science 262: 909.
131. Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, Sunderkotter
C, Harms E, Sorg C, Roth J (2000) : Myeloid-related proteins 8 and
14 are specifically secreted during interaction of phagocytes and
activated endothelium and are useful markers for monitoring disease
activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis
Rheum, 43: 628-637.
132. GC Fanning, KI Welsh, C Bunn, R Du Bois and CM Black :
Tissue Typing in Systemic sclerosis Volume 45, Supplement 1,
October , pp. 23-25(3).
133. Geisberger R, Lamers M and Achatz G (2006) : " the dual
expression of IgM and IgD". Immunology 118 (4): 429–37.
134. Gene Mayer (2006) : "Immunology-Chapter Three; Adaptive
Immunity". Microbiology and Immunology On-Line Textbook. USC
School of Medicine.
135. Gene Mayer (2006) : "Immunology - Chapter Two; Complement".
Microbiology and Immunology On-Line Textbook. USC School of
Medicine.
136. Gene Mayer (2006) : Immunology - Chapter ten ,7th
ed; major
histocompatibility complex (MHC) and Tcell receptors - role in
immune responses.
137. Gergely P Jr and Poor G (2004) : Relapsing polychondritis. Best
Pract Res Clin Rheumatol. Oct;18(5): 723-38.
138. Ghaffar, Abdul (2006) : "Immunology-Chapter Seventeen;
Hypersensitivity Reactions". Microbiology and Immunology On-Line
Textbook. USC School of Medicine."
139. Ghersetich I, Comacchi C, Jorizzo JL, et al., (1999) : Proposal for a
working classification of cutaneous vasculitis. Clinics in
Dermatology;17: 499-503.
140. Girardi M (2006) : "Immunosurveillance and immunoregula- tion by
gammadelta T cells". The Journal of Investigative Dermatology Jan.
126 (1): 25–31.
141. Goeddel, DV. (2009) : "Connection Map for Tumor Necrosis Factor
Pathway". Science. http://stke.sciencemag.org/cgi/cm/CMP_7107.
142. Graham RR, Cotsapas C, Davies L, Hackett R, Lessard CJ, Leon
JM, Burtt NP, Guiducci C, Parkin M, Gates C, Plenge RM,
Behrens TW, Wither JE, Rioux JD, Fortin PR, Graham DC, Wong
AK, Vyse TJ, Daly MJ, Altshuler D, Moser KL, Gaffney PM (2008)
: Genetic variants near TNFAIP3 on 6q23 are associated with systemic
lupus erythematosus. Nat Genet , 40:1059-1061.
143. Gran JT, Husby G, and Hordvik M (1985) : Prevalence of
ankylosing spondylitis in males and females in a young middle-aged
population of Tromso, northern Norway. Ann Rheum Dis 44: 359-367,
1985.
144. Greiner A, Plischke H, Kellner H, and Gruber R (2005) :
"Association of anti-cyclic citrullinated peptide antibodies, anti-
citrullin antibodies, and IgM and IgA rheumatoid factors with
serological parameters of disease activity in rheumatoid arthritis". Ann.
N. Y. Acad. Sci. 1050: 295–303.
145. Grezard P, Chafi M, Philippot V, Perrot H and Faisant M (1996) :
Cutaneoius lupus erythematosus and buccal aphthosis after hepatitis B
vaccination in a 6-year-old child. Ann Dermatol Venereo;123: 657-659.
146. Grom AA and Hirsch R (2000) : T-cell and T-cell receptor
abnormalities in the immunopathogenesis of juvenile rheumatoid
arthritis. Current Op Rheumatol, 12: 420-424.
147. Guermonprez P, Valladeau J, Zitvogel L, Théry C, Amigorena S
(2002) : "Antigen presentation and T cell stimulation by dendritic
cells". Annual Review of Immunology 20: 621–67.
148. Hahn, B.H (1998) : Antibodies to DNA. N. Engl. J. Med. 338:1359–
1368.
149. Hajo Haase and Lothar Rink (2009) : Institute of Immunology, The
immune system and the impact of zinc during aging, Germany
Immunity and Ageing 30, 52074 Aachen , 6:9.
150. Hardy R.R. and Hayakawa K. (2001) : Annu. Rev. Immunol.
19:595.
151. Hasegawa M, Sato S, Nagaoka T, Fujimoto M and Takehara K
(2003) : Dermatology; Serum levels of tumor necrosis factor and
interleukin-13 are elevated in patients with localized scleroderma; 207
(2): 141-7.
152. Haseley LA, Wisnieski JJ, Denburg MR, et al., (2005) : Antibodies
to C1q in systemic lupus erythematosus: characteristics and relation to
Fc gamma RIIA alleles. Kidney Int;52:1375–80.
153. Häupl T, Ustensen M, Grützkau A, Burmester G-R, and Villiger
PM (2008) : Interaction between rheumatoid arthritis and pregnancy:
correlation of molecular data with clinical disease activity measures.
Rheumatology 47(Suppl 3): iii19–22.
154. Hautmann and Lotti T (1999) : The many faces of cutaneous
vasculitis. Clin Derm;17: 515-31.
155. Hayakawa K. et al., (1999) : Science 285:113.
156. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R,
Kwoh CK, et al., (2008) : Estimates of the prevalence of arthritis and
other rheumatic conditions in the United States. Part I. Arthritis
Rheum. Jan ;58(1): 15-25.
157. Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon
D, et al., (2007) : A putative RUNX1 binding site variant between
SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.
Nat Genet;35: 349–56.
158. Herroelen L, De Keyser J and Ebinger G (1991) : Central-nervous
system demyelination after immunisation with recombinant hepatitis B
vaccine. Lancet;338: 1174.
159. Hewett D, Samuelsson L, Polding J, Enlund F, Smart D, Cantone
K, et al., (2002) : Identification of a psoriasis susceptibility candidate
gene by linkage disequilibrium mapping with a localized single
nucleotide polymorphism map. Genomics;79: 305–14.
160. Hinks A, Ke X, Barton A, et al., (2009) : Association of the
IL2RA/CD25 gene with juvenile idiopathic arthritis. Arthritis
Rheum. Jan; 60(1): 251-7.
161. Holtmeier W and Kabelitz D (2005) : "gammadelta T cells link
innate and adaptive immune responses". Chemical Immunology and
Allergy 86: 151–83.
162. Holtmeier W and Kabelitz D (2005) : "gammadelta T cells link
innate and adaptive immune responses". Chemical Immunology and
Allergy 86: 151–83.
163. Huber R (1980) : "Spatial structure of immunoglobulin molecules".
Klin Wochenschr 58 (22): 1217–31.
164. Hutloff A. et al., (1999) : Nature 397: 263.
165. I. Baumann, W. Kolowos, R.E. Voll, B. Manger, U. Gaipl, W.L.
Neuhuber, T. Kirchner, J.R. Kalden, and M. Herrmann (2002) :
Impaired uptake of apoptotic cells into tingible body macrophages in
germinal centers of patients with systemic lupus erythematosus.
Arthritis Rheum. 46:191–201.
166. Iain B McInnes and Georg Schett (2007) : Cytokines in the
pathogenesis of rheumatoid arthritis Nature Reviews Immunology ,
June 7, 429-442.
167. Inman RD (2009) : Innate immunity of spondyloarthritis; the role of
toll-like receptors. Adv Exp Med Biol.;649: 300-9.
168. Israel F. Charo and Richard M. Ransohoff (2006) : The many roles
of chemokines and chemokine receptors in inflammation; Volume 354:
610-621.
169. Itoh K, Sakakibara M, Yamasaki S, Takeuchi A, Arase H,
Miyazaki M, et al., (2006) : Cutting edge: negative regulation of
immune synapse formation by anchoring lipid raft to cytoskeleton
through Cbp-EBP50-ERM assembly. J Immunol;168: 541–4.
170. J. Tian, A.M. Avalos, S.Y. Mao, B. Chen, K. Senthil, H. Wu, P.
Parroche, S. Drabic, D. Golenbock, C. Sirois, et al., (2007) : Toll-
like receptor 9-dependent activation by DNA-containing immune
complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 8:487–
496.
171. Janeway CA, et al., (2008) : Immunobiology; the immune system in
health and disease. 7th ed. New York: Garland Science/Churchill
Livingstone.
172. Janeway Charles A.; Travers, Paul; Walport, Mark; Shlomchik,
Mark(2005) : Immunobiology; the immune system in health and
disease (6th ed), Garland Science.
173. Jarvis JN, Dozmorov I, Jiang K, Frank MB, Szodoray P, Alex P,
Centola M (2004) : Novel approaches to gene expression analysis of
active polyarticular juvenile rheumatoid arthritis. Arthritis Res Ther ,
R15-R32.
174. Jarzabek-Chorzelska M, Blaszczyk M, Jablonska S, Chorzelski T,
Kumar V, Beutner EH (1986) : Scl 70 antibody--a specific marker of
systemic sclerosis. Br J Dermatol Oct;115(4) :393-401.
175. Jasin HE, (1989) : Immune mechanisms in osteoarthritis. Semin
Arthritis Rheum; 18:86
176. Jayne D and Tyndall A (2004) : Autologous stem cell transplanta -
tion for systemic lupus erythematosus. Lupus 13(5), 359–365.
177. Jefferson R Roberts, (2010) : http://www.britannica.com/
EBchecked/topic/623748/vasculitis.
178. Jeffrey P Callen, (2009) : http//emedicine.medscape.com/
article/33137-vasculitis.
179. Jelaska A, Arakawa M, Broketa G, Korn JH (1996) :
Heterogeneity of collagen synthesis in normal and systemic sclerosis
skin fibroblasts. Increased proportion of high collagen-producing cells
in systemic sclerosis fibroblasts. Arthritis Rheum. Aug; 39 (8): 1338-
46.
180. Jiang K, Chen Y, Xu C-S, Jarvis JN (2004) : T Cell activation by
soluble C1q-bearing immune complexes: implications for the
pathogenesis of rheumatoid arthritis. Clin Exp Immunol., 131: 61-67.
181. Jin, Y., L. Fuller, G. Ciancio, G.W. Burke III, A.G. Tzakis, C.
Ricordi, J. Miller, and V. Esquenzai. (2004) : Antigen presentation
and immune regulatory capacity of immature and mature-enriched
antigen presenting (dendritic) cells derived from human bone marrow.
Hum. Immunol., 65: 93–103.
182. Johansson SG, (2006) : "The discovery of immunoglobulin E".
Allergy and asthma proceedings : the official journal of regional and
state allergy societies 27 (2 Suppl 1): S3–6.
183. John Reveille and Matthew Brown (2010) : Nature Genetics 10.
Genome-wide association study of ankylosing spondylitis identifies
non-MHC susceptibility loci, January.
184. John Wiley (2007) : Systemic lupus erythematosus (SLE). Finnish
Medical Society Duodecim EBM Guidelines. Evidence-Based
Medicine.
185. Johnson E and Brehm-Stecher B (2006) : "Single-cell microbiology;
tools, technologies, and applications". Microbiol Mol Biol Rev 68 (3):
538–59.
186. Jon Giles (2009) : Do Occupational Exposures Increase the Risk of
Death from Systemic Autoimmune Disease? June 34 (5): 352
187. Jones DA, Jennette JC, Falk RJ (1990) : Goodpasture's syndrome
revisited; A new perspective on glomerulonephritis and alveolar
hemorrhage. N C Med J;51: 411-5.
188. Jonuleit H, et al., (2000) : J. Exp. Med. 192:1213.
189. Jun JB, Kuechle M, Harlan JM, and Elkon KB (2003) : Fibroblast
and endothelial apoptosis in systemic sclerosis. Curr Opin
Rheumatol. Nov; 15 (6): 756-60.
190. K Hoebe, E Janssen and B Beutler (2004) : The interface between
innate and and adaptive immunity and MHC; Nature Immunology;
Oct., vol. 5:10.
191. K. Hanke, (2009) : Arthritis Research and Therapy, 11:R28.
192. Kallenberg CG, Mulder AH, Tervaert JW (1992) : Antineutrophil
cytoplasmic antibodies (ANCA); A still-growing class of
autoantibodies in inflammatory disorders. Am J Med, 93: 675.
193. Kallenberg M, (2008) : Pathogenesis of PR3-ANCA associated
vasculitis. J Autoimmun. February-March; 30: 29-36.
194. Kallenberg M, Heeringa P, Stegeman CA (2006) : Mechanisms of
disease: pathogenesis and treatment of ANCA-associated
vasculitis. Nat Clin Pract Rheumatol. December; 2: 661-670.
195. Kalogerou A, Gelou E, Mountantonakis S, Settas L, Zafiriou E,
Sakkas L (2006) : Early T cell activation in the skin from patients with
systemic sclerosis. Ann Rheum Dis. Aug;64 (8): 1233-5.
196. Kang SM and Compans RW (2009) : Host responses from innate to
adaptive immunity After vaccination: Molecular and cellular events.
Mol Cells Feb 28;27(1): 5-14.
197. Kanneganti TD, Lamkanfi M and Núñez G (2007) : Intracellular
NOD-like receptors in host defense and disease. Immunity.Oct;27 (4):
549-59.
198. Kariyawasam HH and Robinson DS (2006) : "The eosinophil: the
cell and its weapons, the cytokines, its locations". Seminars in
Respiratory and Critical Care Medicine 27(2): 117–27.
199. Karp DR, Marthandan N, Marsh SG, Ahn C, Arnett FC, Deluca
DS, Diehl AD, Dunivin R, Eilbeck K, Feolo M, Guidry PA,
Helmberg W, Lewis S, Mayes MD, Mungall C, Natale DA, Peters
B, Petersdorf E, Reveille JD, Smith B, Thomson G, Waller MJ, and
Scheuermann RH (2010) : "Novel sequence feature variant type
analysis of the HLA genetic association in systemic sclerosis.". Human
Molecular Genetics 19 (4): 707–719.
200. Katharina Hanke, (2009): Antibodies against PM/Scl-75 and
PM/Scl-100 are independent markers for different subsets of systemic
sclerosis patients. Arthritis Research and Therapy, 11: R22.
201. Kavanaugh A, Tomar R, Reveille J, Solomon DH, and Homburger
HA (2000) : Guidelines for clinical use of the antinuclear antibody test
and tests for specific autoantibodies to nuclear antigens. American
College of Pathologists. Arch Pathol Lab Med;124: 71-81.
202. Kawai T and Akira S (2006) : "Innate immune recognition of viral
infection" Nature Immunology 7(2): 131–7.
203. Kawakami T, Tsutsumi Y, Soma Y (2009) : Limited cutaneous
systemic sclerosis induced by paclitaxel in a patient with breast
cancer. Arch Dermatol. Jan;145(1): 97-8.
204. Kawakami T, Yamazaki M, Mizoguchi M, Soma Y (2008) : High
titer of serum antiphospholipid antibody levels in adult Henoch-
Schönlein purpura and cutaneous leukocytoclastic angiitis. Arthritis
Rheum. Apr 15;59 (4): 561
205. Kee B.L. and Murre C. (2001) : Curr. Opin. Immunol. 13:180.
206. Kelly. J., (2009) : The Cutoff Points of Antinuclear Antibody (ANA)
with High Negative and Positive Predictive Values. Analysis of 5655
Cases. Aug 12, Musculoskeletal Report.
207. Kelton. JG, (1981) : Vaccination-associated relapse in immune
thrombocytopenia. JAMA; 245: 369-71.
208. Keren DF, (2002) : Clin Lab Med. Antinuclear antibody testing..
Warde Medical Laboratory, Department of Pathology, University of
Michigan Medical School, Ann Arbor, MI 48108, USA. Jun;22 (2):
447-74.
209. Kimball, (2010) : hla.alleles.org
210. Kiss E, Csipo I, Cohen JH, et al., (2004) : CR1 density
polymorphism and expression on erythrocytes of patients with systemic
lupus erythematosus. Autoimmunity;25: 53–8.
211. Klein J and Sato A (2000) : "The HLA system. Second of two parts".
N. Engl. J. Med. September, 343 (11): 782–6.
212. Klinman DM, Shirai A, Ishigatsubo Y, et al., (2003) : Quantitation
of IgM- and IgG-secreting B cells in the peripheral blood of patients
with systemic lupus erythematosus. Arthritis Rheum; 34: 1404–10.
213. Kokkonen, (2010) : H. Arthritis and Rheumatism, Feb. 2, vol 62: pp
383-391.
214. Koopman, William, et al., (2003) : Clinical Primer of Rheumatology.
Philadelphia: Lippincott.
215. Kouskoff V and Nemazee D (2001) : Life Sci. 69:1105.
216. Kouskoff V. et al., (2000) : Science 287:2501.
217. Kovacs B, Maus MV, Riley JL, et al., (2002) : "Human CD8+ T
cells do not require the polarization of lipid rafts for activation and
proliferation". Proceedings of the National Academy of Sciences of the
United States of America November 99 (23): 15006–11.
218. Krisha (2009) : http://www.everydayhealth.com/autoimmune-
disorder, EverydayHealth>Women,and Autoimme Disorders."
219. Krivosikova M, Dallos T, Maslinski W, Buc M, Bratisl L
Listy(2009) : crucial role of BAFF in the pathogenesis of RA and SLE
;110 (3): 137-45.
220. Krueger G, Langley R, Leonardi C, Yeilding N, Guzzo C, Wang
Y, Dooley L and Lebwohl M (2007) : "A human interleukin-12/23
monoclonal antibody for the treatment of psoriasis". N Engl J Med 356
(6): 580–92.
221. Krueger G, Langley R, Leonardi C, Yeilding N, Guzzo C, Wang
Y, Dooley L, Lebwohl M (2007) : " susceptibility variants of the MHC
as well as variants that alter T cell responses during development,
during thymic selection, or in the periphery in psoriasis". N Engl J Med
356 (6): 580–92.
222. Krummel M. and J. Allison (1995) : J. Exp. Med. 182:459.
223. Kubach J, Becker C, Schmitt E, Steinbrink K, Huter E,
Tuettenberg A, Jonuleit H (2005) : "Dendritic cells: sentinels of
immunity and tolerance". Int J Hematol 81 (3): 197–203.
224. Kumar H, Kawai T and Akira S (2009) : Pathogen recognition in
the innate immune response Biochem J Apr 28;420 (1): 1-16.
225. Kurosaki T. (2002) : Nat. Rev. Immunol. 2: 354.
226. Kurowski K and Boxer RW (2008) : Food allergies; detection and
management. American Family Physician. June:77:12.
227. Kwara A, Ramachandran G, Swaminathan S (2010) : Expert
Opinion on Drug Metabolism and Toxicology January, 6 (1): 55–68.
228. L Maes (2010) : Antibodies against PM/Scl-75 and PM/ Scl-100 are
independent markers for different subsets of systemic sclerosis patients.
Clin Chim Acta. Jul 4;411(13-14): 965-71.
229. LaFleur-Brooks, M (2008) : Exploring Medical Language: A
Student-Directed Approach, 7th Edition. St. Louis, Missouri, USA:
Mosby Elsevier. pp. 398.
230. Lai-Shan Tam, Jieruo Gu and David Yu (2010) : Genetics
Pathogenesis of ankylosing spondylitis (AS), Nature Reviews
Rheumatology July 6, 399-405.
231. Larsson M. et al., (2001) : Trends Immunol. 22:141.
232. Latchman Y. et al., (2001) : Nat. Immunol. 2:261.
233. Lauhio A, Leirisalo-Repo M, Lähdevirta J, Saikku P, Repo
H (1991) : Double-blind, placebo-controlled study of three-month
treatment with lymecycline in reactive arthritis, with special reference
to Chlamydia arthritis. Arthritis Rheum. Jan ; 34(1): 6-14.
234. Laurent M. Dejean, Sonia Martinez-Caballero, Kathleen W.
Kinnally (2006) : "Is MAC the knife that cuts cytochrome c from
mitochondria during apoptosis?". Cell Death and Differentiation 13 (8):
1387–5.
235. Le Y, Zhou Y, Iribarren P and Wang J (2004) : "Chemokines and
chemokine receptors: their manifold roles in homeostasis and disease".
Cellular and Molecular Immunology April 1(2): 95–104.
236. Lebwohl M (2003) : Psoriasis. Lancet; 361:1197–204.
237. Lechner O. et al., (2001) : Curr. Biol. 11: 587.
238. Lee DM and Schur PH (2003) : Clinical utility of the anti-CCP assay
in patients with rheumatic diseases. Ann Rheum Dis. Sep;62 (9): 870-4.
239. Lee EG, Boone DL, Chai S, Libby SL, Chien M, Lodolce JP, Ma A
(2000) : Failure to regulate TNF-induced NF-kappaB and cell death
responses in A20-deficient mice. Science , 289: 2350-2354.
240. Lefkowitz DL, Gelderman MP, Fuhrmann SR, Graham S, Starnes
JD III, Lefkowitz SS, Bollen A, and Moguilevsky N (1999) :
Neutrophilic myeloperoxidase-macrophage interactions perpetuate
chronic inflammation associated with experimental arthritis. Clin
Immunol, 91: 145-155.
241. Lehnhardt FG, Scheid C, Holtik U et al., (2006) : Autologous blood
stem cell transplantation in refractory systemic lupus erythematodes
with recurrent longitudinal myelitis and cerebral infarction. Lupus
15(4): 240–243.
242. Lenschow D.J et al., (1996) : Annu. Rev. Immunol. 14: 233.
243. Lenzi M, Frisoni M, Mantovani V, et al., (1998) : Haplotype HLA
B-8-DR3 confers susceptibility to hepatitis C virus-related mixed
cryoglobulinemia. Blood; 91: 2062-6.
244. LeRoy EC, Black C, Fleischmajer R, et al., (1988) : Scleroderma
(systemic sclerosis): classification, subsets and pathogenesis. J
Rheumatol. Feb; 15(2): 202-5.
245. Li W, Wang M, Irigoyen P, and Gregersen PK (2006) : Inferring
causal relationships among intermediate phenotypes and biomarkers: a
case study of rheumatoid arthritis. Bioinformatics, 22: 1503-1507.
246. Lieber MR, Yu K and Raghavan SC (2006) : "Roles of
nonhomologous DNA end joining, V(D)J recombination, and class
switch recombination in chromosomal translocations". DNA Repair
(Amst.) 5 (9-10): 1234–45.
247. Lindenmann Jean (1984) : "Origin of the Terms 'Antibody' and
'Antigen'". Scand. J. Immunol. 19 (4): 281–5.
248. Ling V et al., (2000) : J. Immunol. 164:1653.
249. Linker-Israeli M, Deans RJ, Wallace DJ, et al., (2005) : Elevated
levels of endogenous IL-6 in systemic lupus erythematosus. A putative
role in pathogenesis. J Immunol; 147: 117–23.
250. Liossis SN, Kovacs B, Dennis G, et al., (2005) : B cells from patients
with systemic lupus erythematosus display abnormal antigen receptor-
mediated early signal transduction events. J Clin Invest 98: 2549–57.
251. Litman GW, Cannon JP, and Dishaw LJ (2005) : "Reconstructing
immune phylogeny: new perspectives". Nature Reviews. Immunology
5(11):866–79.
252. Little MA et al., (2005) : Antineutrophil cytoplasm antibodies
directed against myeloperoxidase augment leukocyte-microvascular
interactions in vivo. Blood 106: 2050-2058.
253. Liu LJ, Chen M, Yu F, Zhao MH, and Wang HY (2008) :
Evaluation of a new algorithm in classification of systemic
vasculitis. Rheumatology (Oxford). May;47(5): 708-12.
254. Llewelyn M and Cohen J (2002) : "Superantigens: microbial agents
that corrupt immunity". Lancet Infect Dis March 2 (3): 156–62.
255. Lohmann T. et al., (1996) : J. Autoimmun. 9: 385.
256. Longmore M, Wilkinson I.B and Rajagopalan S.R (2004) : Oxford
Handbook of Clinical Medicine; 6th ed, OUP.
257. Lotti TM, Comacchi C, and Gersetich I.(1999) : Cutaneous
necrotizing vasculitis: Relation to systemic disease. Rheumaderm ; 55:
115-25.
258. Lovy MR, Starkebaum G, Uberoi S (1996) : "Hepatitis C infection
presenting with rheumatic manifestations: a mimic of rheumatoid
arthritis." J. Rheumatol 23 (6): 1238–9.
259. Luime JJ, Colin EM, Hazes JM, Lubberts E (2009) : " Additional
value of cytokines in the diagnostic and prognostic work-up of patients
with rheumatoid arthritis? A systematic review.". Ann Rheum Dis. Mar
15.69 (2): 337–44.
260. M K Crow (2004) : Autoimmun Rev. Nov; 3 (7-8): 500-4.
261. M K Crow (2008) : Arthritis Research and Therapy , 10:126.
262. M. Adler, S. Schulz, and M. Spengler (2009) : Cytokine
Quantification in Drug Development: A comparison of sensitive
immunoassay platforms. Chimera Biotech. (Report).
263. Mackay C.R. (2001) : Nat. Immunol. 2:95.
264. Maeda Y. et al., (2001) : Immunobiology 204:442.
265. Mankin, HJ, Dorfman, HD, Lipiello, L, et al., (1971) :
Biochemical and metabolic abnormalities in articular cartilage from
osteoarthritic human hips. II. Correlation of morphology with
metabolic data. J Bone Joint Surg; 53A: 523.
266. Maria Trojanowska, (2010) : Nature Reviews Rheumatology,
10.1038/nrrheum.102
267. Mariathasan S et al., (2001) : J. Immunol. 167: 4966.
268. Mark P. Mattson & Sic L. Chan (2003) : Calcium orchestrates
apoptosis. Nature Cell Biology 5, 1041 - 1043.
269. Marrack JR, (1938) : Chemistry of antigens and antibodies (2nd ed)
London: His Majesty's Stationery Office.
270. Martensson G and Ceredig S (2000) : J. Immunol. 147:766.
271. Martin F Flajnik and Masanori Kasahara (2010) : Origin and
evolution of the adaptive immune system: genetic events and selective
pressures, Nature Reviews Genetics 11, 47-59.
272. Martin P and Leibovich SJ (2005) : "Inflammatory cells during
wound repair: the good, the bad and the ugly". Trends in Cell Biology
November,15(11):599–607.
273. Masaki Nagai, (2004): Journal of Investigative Dermatology 122,
594–601.
274. Matera L, (1997) : Action of pituitary and lymphocyte prolactin.
Neuroimmunomodulation;4:171–80.
275. Matsushita T, Hasegawa M, Matsushita Y, Echigo T, Wayaku T,
Horikawa M, Ogawa F, Takehara K, and Sato S (2007) : Exp
Dermatol., Feb;16 (2): 87-93.
276. Matteson EL, (1999) : A history of early investigation in polyarteritis
nodosa. Arthritis Care Res; 12: 294-302.
277. Mattu T, Pleass R, Willis A, Kilian M, Wormald M, Lellouch A,
Rudd P, Woof J and Dwek R (1998) : "The glycosylation and
structure of human serum IgA1, Fab, and Fc regions and the role of N-
glycosylation on Fc alpha receptor interactions". J Biol Chem 273 (4):
2260–72.
278. Matzinger P, (2002) : "The danger model: a renewed sense of self".
Science April, 296(5566): 301–5.
279. May E, Dulphy N, Frauendorf E, Duchmann R, Bowness P, Lopez
de Castro JA, et al., (2002) : Conserved TCR beta chain usage in
reactive arthritis; evidence for selection by a putative HLA-B27-
associated autoantigen. Tissue Antigens 60: 299-308.
280. McCombe PA, Greer JM, and Mackay IR (2009) : Sexual
dimorphism in autoimmune disease. Curr Mol Med. Dec;9(9):1058-79.
281. McGonagle, Dennis, Aziz, Azad, Dickie, Laura J., McDermott,
Michael F (2009) : Infections and Immunity: Immune Regulation and
Inflammation; Volume 65 - Issue 5 Part 2 - pp 38R-45R.
282. McHeyzer-Williams LJ, Malherbe LP and McHeyzer-Williams
MG (2006) : "Helper T cell-regulated B cell immunity". Current
Topics in Microbiology and Immunology 311: 59–83.
283. McMurray RW, Ndebele K, Hardy KJ, et al., (2007) : 17-beta-
estradiol suppresses IL-2 and IL-2 receptor. Cytokine;14: 324–33.
284. Medzhitov R, (2007) : "Recognition of microorganisms and
activation of the immune response". Nature 449 (7164): 819–26.
285. Meffre E, et al., (2000) : Nat. Immunol. 1:207.
286. Meier CR, Sturkenboom MC, Cohen AS, et al.,(1998) :
Postmenopausal estrogen replacement therapy and the risk of
developing systemic lupus erythematosus or discoid lupus. J
Rheumatol; 25: 1515–19.
287. Messmer, D., H. Yang, G. Telusma, F. Knoll, J. Li, B. Messmer,
K.J. Tracey, and N. Chiorazzi (2004) : High mobility group box
protein 1: an endogenous signal for dendritic cell maturation and Th1
polarization. J. Immunol. 173:307–313.
288. Mian I, Bradwell A and Olson A (1991) : "Structure, function and
properties of antibody binding sites". J Mol Biol 217 (1): 133–51.
289. Michael G Rossman, (2010) : Some association exists between
hepatitis B infection and PAN : http://www.britannica.com/
EBchecked/topic/623748/vasculitis
290. Mierau and Genth (2006) : Scleroderma associated autoantibodies -
clinical and diagnostic relevance. Z Rheumatol. Jun 21.
291. Milland J and Sandrin MS (2006) : "ABO blood group and related
antigens, natural antibodies and transplantation". Tissue Antigens 68
(6): 459–66.
292. Miller C, Ragheb JA, Schwartz RH (1999) : "Anergy and cytokine-
mediated suppression as distinct superantigen-induced tolerance
mechanisms in vivo". J. Exp. Med. July, 190 (1): 53–64.
293. Miller NW, Bengtén E, Edholm ES, Santini PA, Rath P, Chiu A,
Cattalini M, Litzman J, B Bussel J, Huang B, Meini A, Riesbeck K,
Cunningham-Rundles C, Plebani A, Cerutti A (2009) :
Immunodeficiency; genetic factor; Nature Immunology 10 (8): 889–98.
294. Millikan LE, Flynn TC and Muckelaman R (2007) : Infectious
etiologies of cutaneous vasculitis. Clin Dermatol;17: 509-14.
295. Miniati I, Guiducci S, Mecacci F, Mello G, Matucci-Cerinic M
(2008) : Pregnancy in systemic sclerosis. Rheumatology 47(Suppl
3):iii16–18.
296. Minoru Satoh, Monica Vázquez-Del Mercado,
and Edward K L
Chan (2009) : Clinical interpretation of antinuclear antibody tests in
systemic rheumatic diseases. Modern Rheumatology. March 11.
297. Minskoff S.A, et al., (1998) : J. Immunol. 161:2079.
298. Mir A, Porteu F, Levy M, et al., (1988) : C3b receptor (CR1) on
phagocytic cells from SLE patients: analysis of the defect and familial
study. Clin Exp Immunol;73: 461–6.
299. Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K;
Fausto and Nelson (2007) : Robbins Basic Pathology. Philadelphia:
Saunders.8th edition.
300. Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K;
Fausto; and Nelson Robbins (2007) : Basic Pathology. Philadelphia:
Saunders. Hypersensitivity; 8th edition pp:53-65.
301. Mohammed Mubashir Ahmed, (2010) : http://www. britannica.com
/EBchecked/topic/331037/vasculitis
302. Mok CC and Lau CS (2006) : Profile of sex hormones in patients
with systemic lupus erythematosus. Lupus;9: 252–7.
303. Molina and Shoenfeld (2005) : "Infection, vaccines and other
environmental triggers of autoimmunity". Autoimm unity, May;38(3)
:235-4
304. Monie TP, Moncrieffe MC, Gay NJ (2009) : Immunol Rev Jan;227
(1): 161-75. Structure and regulation of cytoplasmic adapter proteins
involved in innate immune signaling.
305. Moosig F, Lamprecht P, and Gross WL (2008) : Wegener's
Granulomatosis: the current view. Clin Rev Allergy
Immunol. October;35(1-2): 19-21.
306. Morimoto C, Romain PL, Fox DA, Anderson P, DiMaggio M,
Levine H, and Schlossman SF (1988) : Abnormalities in CD4+ T-
lymphocyte subsets in inflammatory rheumatic diseases. Am J Med,
84: 817-825.
307. Muhammed Muneer, (2010) : http://www.similima.Com path
11.html
308. Mukundan Attur, Hayf E. Al-Mussawir, Jyoti Patel, Alison Kitay,
Mandar Dave, Glyn Palmer, Michael H. Pillinger and Steven B.
Abramson (2008) :
The Journal of Immunology, 181, 5082 -5088.
309. Murphy KM, Ranganathan V, Farnsworth ML, Kavallaris M,
Lock RB (2000) : "Bcl-2 inhibits Bax translocation from cytosol to
mitochondria during drug-induced apoptosis of human tumor cells".
Cell Death Differ. January. 7 (1): 102–11.
310. Musone SL, Taylor KE, Lu TT, Nititham J, Ferreira RC,
Ortmann W, Shifrin N, Petri MA, Kamboh MI, Manzi S, Seldin
MF, Gregersen PK, Behrens TW, Ma A, Kwok PY, Criswell LA
(2008) : Multiple polymorphisms in the TNFAIP3 region are
independently associated with systemic lupus erythematosus. Nat
Genet;40:1062–1064.
311. N. A. Fathi, (2008) : Antiphospholipid Antibodies (aPL) And
Vascular Endothelial Growth Factor In Systemic Lupus Erythematosus,
AB0974-AHP. EULAR
312. N. U. Radoja, Wang, D., M. Hevey, L. Y. Juompan and C. M.
Trubey (2006) : Killer T cells are activated when their receptor (TCR)
binds to this specific antigen in a complex with the MHC Class I
receptor.J. Immunology, 164: 2619-2628.
313. Nakamura K, et al., (2001) : J. Exp. Med. 194:629.
314. Nathan C, (2002) : Inflammation: points of control. Nature , 420:846-
852.
315. Nathan C, (2006) : Neutrophils and immunity: challenges and
opportunities. Nature Rev Immunol, 6:173-182.
316. Nelson JL, Furst DE, Maloney S, et al., (1998) : Microchimerism
and HLA-compatible relationships of pregnancy in scleroderma. Lancet
Feb 21;351(9102): 559-62.
317. Nemazee D, (2006) : "Receptor editing in lymphocyte development
and central tolerance". Nat Rev Immunol 6 (10): 728–40.
318. Nicaise Roland P, Grootenboer Mignot S, Bruns A, et al., (2008) :
"Antibodies to mutated citrullinated vimentin for diagnosing
rheumatoid arthritis in anti-CCP-negative patients and for monitoring
infliximab therapy". Arthritis Res. Ther. 10 (6): R142.
319. Nicola Bizzaro, (2008) : The Predictive Significance of
Autoantibodies in Organ-Specific Autoimmune Diseases Clinical
Reviews in Allergy and Immunol Volume 34, Number 3, 326-331.
320. Nihtyanova SI and Denton CP (2010) : Autoantibodies as predictive
tools in systemic sclerosis. Strong links exist between autoantibody
specificities and disease presentation and outcome. Nat Rev
Rheumatol. 36 (1): 93-103.
321. Niles JL, Bottinger EP, Saurina GR, et al., (1996) : The syndrome
of lung hemorrhage and nephritis is usually an ANCA associated
condition. Arch Intern Med;156:440-5.
322. Nishimoto N, (2010) : Interleukin-6 as a therapeutic target in
candidate inflammatory diseases. Clin Pharmacol Ther. Apr ;87 (4):
483-7.
323. Nishimura K, Sugiyama D, Kogata Y, et al., (2007) : "Meta-
analysis: diagnostic accuracy of anti-cyclic citrullinated peptide
antibody and rheumatoid factor for rheumatoid arthritis". Annals of
Internal Medicine 146 (11): 797–808.
324. Nishimura K, Sugiyama D, Kogata Y, et al., (2007) : "Meta-
analysis: diagnostic accuracy of anti-cyclic citrullinated peptide
antibody and rheumatoid factor for rheumatoid arthritis" (PDF). Ann.
Intern. Med. June, 146 (11): 797–808.
325. Notarangelo LD, (2010) : Primary immunodeficiencies. J Allergy
Clin Immunol. Feb ;125(2 Suppl 2): S182-94.
326. Ogawa Y and Calhoun WJ (2006) : "The role of leukotrienes in
airway inflammation". The Journal of Allergy and Clinical
Immunology 118 (4): 789–98; quiz 799–800.
327. Ohashi, P. (2002) : illustration has been adapted from Nat. Rev.
Immunol. 2:427.
328. Or-Guil M, Wittenbrink N, Weiser AA and Schuchhardt J (2007)
: "Recirculation of germinal center B cells: a multilevel selection
strategy for antibody maturation". Immunol. Rev. 216: 130–41.
329. Oshima M, Deitiker P, Ashizawa T, Atassi M (2002) : "Vaccination
with a MHC class II peptide attenuates cellular and humoral responses
against tAChR and suppresses clinical EAMG". Autoimmunity 35 (3):
183–90.
330. P. P. Y. Lui, L. s. Chan, S. c. Fu, and K. m. Chan (2010) :
Expression of Sensory Neuropeptides in Tendon Is Associated With
Failed Healing and Activity-Related Tendon Pain in Collagenase-
Induced Tendon Injury. Am. J. Sports Med. 38, 757-764.
331. P. Wang, F. Zhu, and K. Konstantopoulos (2010) : Am J Physiol
Cell Physiol, June 1,298(6): C1445 - C1456.
332. Pagana KD and Pagana TJ (2006) : Mosby’s Manual of Diagnostic
and Laboratory Tests, 3rd ed.
333. Palm NW and Medzhitov R (2009) : Pattern recognition receptors
and control of adaptive immunity. Immunol Rev. Jan; 227 (1): 221-33.
334. Pamela H Kempert, (2010) : http://emedicine.medscape.com/
article/960027/overview
335. Pannu J, Asano Y, Nakerakanti S, et al.,(2008) : Smad1 pathway is
activated in systemic sclerosis fibroblasts and is targeted by imatinib
mesylate. Arthritis Rheum. Aug;58(8): 2528-37.
336. Papiernik M, et al., (1997) : Int. Immunol. 10:371.
337. Parisi G, (1990) : "A simple model for the immune network". Proc.
Natl. Acad. Sci. USA 87: 429-433.
338. Park MC, Lee SW, Park YB, Chung NS, Lee SK (2005) : Clinical
characteristics and outcomes of Vasculitis of the central nervous
system: analysis of 108 patients using standardized criteria for
diagnosis, activity assessment, and angiographic classification. Scand J
Rheumatol. Jul-Aug;34(4):284-92.
339. Parker CW, (1975) : Drug allergy. N Engl J Med; 292: 511-4.
340. Parker D, (1993) : "T cell-dependent B cell activation". Annu. Rev.
Immunol. 11: 331–60.
341. Parks C G, Conrad K, and Cooper G S (1999) : Environ Health
Perspect. October; 107(Suppl5): 793–802. Occupational exposure to
crystalline silica and autoimmune disease.
342. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J (2005) :
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset
juvenile idiopathic arthritis and clinical response to IL-1 blockade. J
Exp Med, 201: 1479-1486.
343. Paul A. Linnemeyer (2008) : The Immune System -An Overview
Seattle Treatment Education Project http://wwfw.thebody.com/
content/art1788.html
344. Perez C, Mendoza H, Hernandez R, Valcayo A, and Guarch R
(1997) : Leukocytoclastic vasculitis and polyarthritis associated with
Mycoplasma pneumoniae infection. Clin Infect Dis; 25:154-5.
345. Peter Parham, (2005) : "The Immune System. 2nd ed. Garland
Science: New York, pg.47-62.
346. Petty RE and Cassidy JT (2001) : Juvenile Rheumatoid Arthritis. In
Textbook of Pediatric Rheumatology. Edited by: Cassidy JT, Petty RE.
Philadelphia: WB Saunders Co;p 262.
347. Phillip R and Luqmani R (2008) : Mortality in systemic vasculitis: a
systematic review. Clin Exp Rheumatol. September-October
2008;26:S94-S104.
348. Piccirillo C and Shevach E.M (2001) : J. Immunol. 167:1137.
349. Pichlmair A and Reis e Sousa C (2007) : innate recognition.
Immunity; 27:370-383.
350. Pier GB, Lyczak JB and Wetzler LM (2004) : Immunology,
Infection, and Immunity. ASM Press.
351. Pierce and Benjamin A (2010) : Genetics: A Conceptual Approach.
2nd edition.
352. Pierce S.K, (2002) : Nat. Rev. 2:96.
353. Pierce, S.K. (2002) : illustration has been adapted from Nat. Rev.
2:96.
354. Pike B, Boyd A, Nossal G (1982) : Clonal anergy: the universally
anergic B lymphocyte". Proc Natl Acad Sci USA 79 (6): 2013–7.
355. Pincus T, (2006) : Advantages and limitations of quantitative
measures to assess rheumatoid arthritis - joint counts, radiographs,
laboratory tests, and patient. Bull Hosp Jt Dis., 64 (1-2): 32-9.
356. Pisetsky DS, (1997) : Systemic lupus erythematosus. A.
Epidemiology, pathology and pathogenesis. In: Klippel JH, ed. Primer
on the rheumatic diseases11th ed. Georgia, USA: Arthritis Foundation,
246–51.
357. Plenge RM, Seielstad M, Padyukov L, et al., (2007) : "TRAF1-C5
as a risk locus for rheumatoid arthritis-a genomewide study". N. Engl.
J. Med. September 357 (12): 1199–209.
358. Poole BD, Schneider RI, Guthridge JM, et al., (2009) : "Early
targets of nuclear RNP humoral autoimmunity in human systemic lupus
erythematosus". Arthritis Rheum. February 60 (3): 848–859.
359. Popov SG, Villasmil R, Bernardi J (2002) : "Lethal toxin of Bacillus
anthracis causes apoptosis of macrophages". Biochem. Biophys. Res.
Commun. April 293 (1): 349–55.
360. Pravitt Gourh, (2009): Plasma cytokine profiles in systemic sclerosis
(SSc): associations with autoantibody subsets and clinical
manifestations Arthritis Research and Therapy Feb12; (7th Space).
361. Prescott SL, (2009) : Role of dietary immunomodulatory factors in
the development of immune tolerance.;64:185-94; discussion 194-200,
251-7. Aug 19.
362. Preud'homme JL, Petit I, Barra A, Morel F, Lecron JC and
Lelièvre E (2000) : "Structural and functional properties of membrane
and secreted IgD". Mol. Immunol. 37 (15): 871–87.
363. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L,
Magnusson V, et al., (2002) : A regulatory polymorphism in PDCD1
is associated with susceptibility to systemic lupus erythematosus in
humans. Nat Genet;32:666–9.
364. Putnam FW, Liu YS and Low TL (1979) : "Primary structure of a
human IgA1 immunoglobulin. IV. Streptococcal IgA1 protease,
digestion, Fab and Fc fragments, and the complete amino acid sequence
of the alpha 1 heavy chain". J Biol Chem 254 (8): 2865–74.
365. Racaniello and Vincent (2009) : "Natural antibody protects against
viral infection". Virology Blog. http://www.virology.ws/natural-
antibody-protects-against-viral-infection.
366. Radice A and Sinico RA (2005) : Antineutrophil cytoplasmic
antibodies (ANCA). Autoimmunity; 38 (1): 93-103.
367. Rahman P and Elder JT (2005) : Genetic epidemiology of psoriasis
and psoriatic arthritis. Ann Rheum Dis;64 (suppl II): ii37–9.
368. Rahman P, Bartlett S, Siannis F, Pellett FJ, Farewell VT, Peddle
L, et al., (2006) : CARD15; a pleiotropic autoimmune gene that
confers susceptibility to psoriatic arthritis. Am J Hum Genet;73: 677–
81.
369. Raju TN, (1999) : "The Nobel chronicles.1972: Gerald M Edelman (b
1929) and Rodney R Porter (1917-85)". Lancet 354 (9183): 1040.
370. Raptopoulou A, Sidiropoulos P, Katsouraki M, Boumpas DT
(2007) : "Anti-citrulline antibodies in the diagnosis and prognosis of
rheumatoid arthritis: evolving concepts". Crit Rev Clin Lab Sci 44 (4):
339–63.
371. Ravetch J and Bolland S (2001) : "IgG Fc receptors". Annu Rev
Immunol 19: 275–90.
372. Reece, Jane, Campbell and Neil (2002) : Biology. San Francisco:
Benjamin Cummings. p.907.
373. Renaudineau Y and Le Meur Y (2008) : pathogenic mechanism of
Renal involvement in Wegener's Granulomatosis. Clinic Rev Allerg
Immunol. October (35): 22-29.
374. Retter M.W and Nemazee D (1998) : J. Exp. Med. 188:1231.
375. Reumaux D, Duthilleul P and Roos D (2004) : Pathogenesis of
diseases associated with antineutrophil cytoplasm autoantibodies. Hum
Immunol; 65 (1): 1-12.
376. Reveille JD, (2006) : The genetic basis of ankylosing spondylitis.
Curr Opin Rheumatol 18: 332-341.
377. Rhen T and Cidlowski JA (2005) : Antiinflammatory action of
glucocorticoids; The immunosuppressive macrolides new mechanisms
for old drugs. N Engl J Med. Oct 20;353 (16): 1711-23.
378. Richmond H and Morton R (1948) : Presentation of two bone
marrow components, the tart cell and the LE cell. Mayo Clin Proc; 27:
25–28.
379. Ricklin D and Lambris JD (2007) : Complement-targeted
therapeutics. Nat Biotechnol; 25: 1265.
380. Rider V, Jones S, Evans M, et al., (2004) : Estrogen increases CD40
ligand expression in T cells from women with systemic lupus
erythematosus. J Rheumatol ;28: 2644–9.
381. Rioux JD and Abbas AK (2005) : Paths to understanding the genetic
basis of autoimmune disease. Nature 435: 584–589.
382. Robert A Schwartz, Bozena Dziankowska-Bartkowiak, Anna
Zalewska, Anna Sysa-Jedrzejowska, (2010) : "Autoimmunogenic
aspect of systemic sclerosis;" J Rheumatol, May 26.
383. Rolink A.G. et al., (2001) : Curr. Opin. Immunol. 13:202.
384. Rolink A.G. et al., (2001) : Immunity 12:619.
385. Roopa Srinivasan, Alan N. Houghton, and Jedd D. Wolchok
(2002) : Induction of autoantibodies against tyrosinase-related proteins
following DNA vaccination: Unexpected reactivity to a protein
paralogue.
386. Rose M, (2001) : Mutation in Ig V-gene and autoimmunity; J
Autoimun; 14: 1-10.
387. Rose HM, Ragan E, Pearce E and Lipman MO (1948) :
"Differential agglutination of normal and sensitized sheep erythrocytes
by sera of patients with rheumatoid arthritis". Proc Soc Exp Biol Med
68: 1–11.
388. Rostaing L, Modesto A, Cisterne JM, Izopet J, Oksman F, Duffaut
M, Abbal M and Durand D (1998) : "Serological markers of
autoimmunity in renal transplant patients with chronic hepatitis C".
American journal of nephrology 18 (1): 50–56.
389. Roux K, (1999) : "Immunoglobulin structure and function as revealed
by electron microscopy". Int Arch Allergy Immunol 120 (2): 85–99.
390. Rubtsova K, Kappler JW and Marrack P (2010) : Genetic and
hormonal factors in female-biased autoimmunity. Autoimmun Rev.
May;9 (7): 494-8.
391. Rus H, Cudrici C and Niculescu F (2005) : "The role of the
complement system in innate immunity". Immunologic Research 33
(2): 103–12.
392. Ryu J, Treadwell BV, and Mankin HJ (1984) : Biochemical and
metabolic abnormalities in normal and osteoarthritic human articular
cartilage. Arthritis Rheum; 27: 49.
393. S. Leng, J. McElhaney, J. Walston, D. Xie, N. Fedarko and G.
Kuchel (2008) : "Elisa and Multiplex Technologies for Cytokine
Measurement in Inflammation and Aging Research". J Gerontol A Biol
Sci Med Sci October 63: 879–884.
394. Saccardi R, Kozak T, Bocelli-Tyndall C, Fassas A, Kazis A,
Havrdova E, Carreras E, Saiz A, Lwenberg B, Boekhorst PA,
Gualandio F, Openshaw H, Longo G, Pagliai F, Massacesi L,
Deconink E, Ouyang J, Nagore FJ, Besalduch J, Lisukov IA,
Bonini A, Merelli E, Slavino S, Gratwohl A, Passweg J, Tyndall A,
Steck AJ, Andolina M, Capobianco M, Martin JL, et al., (2008) :
SSc and the different types of vasculitis Mult Scler , 12: 814-823.
395. Sakkas LI, (2005) : New developments in the pathogenesis of
systemic sclerosis. Autoimmunity. Mar;38(2): 113-6.
396. Salmon M and Gordon C (1999) : The role of apoptosis in systemic
lupus erythematosus. Rheumatology (Oxford); 38:1177–83.
397. Samejima K, Tone S, Kottke TJ, Enari M, Sakahira H, Cooke CA
et al., (1998) : Transition from caspase-dependent to caspase-
independent mechanisms at the onset of apoptotic execution. J Biol
Chem;143: 225–39.
398. Samuelsson L, Enlund F, Torinsson A, Yhr M, Inerot A,
Enerback C, et al., (1999) : A genome-wide search for genes
predisposing to familial psoriasis by using a stratification approach.
Hum Genet; 105:523–9.
399. Sansom D.M, (2000) : Immunology 101:169.
400. Sansonno D and Dammacco F (2005) : Hepatitis C virus,
cryoglobulinaemia, and vasculitis: immune complex relations. Lancet
Infect Dis. Apr ;5(4):227-36.
401. Saunders K, Raine T, and Lawrence C (2007) : "Localized
autoimmune diseases Infect Immun 75 (3): 397–407.
402. Saunders K, Raine T, Cooke A and Lawrence C (2007) :
"Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth
infection". Infect Immun 75 (1): 397–407.
403. Savage COS, Harper L, and Adu D (1997) : Primary systemic
vasculitis. Lancet;349:553-7.
404. Savill J, (1997) : Recognition and phagocytosis of cells undergoing
apoptosis. Br Med Bull; 53: 491–508
405. Savino W et al., (2002) : Trends Immunol. 23: 305.
406. Scapini P, Carletto A, Nardelli B, Calzetti F, Roschke V, Merigo
F, Tamassia N, Pieropan S, Biasi D, Sbarbati A, Sozzani S,
Bambara L, Cassatella MA (2005) : Proinflammatory mediators elicit
secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that
is stored in activated neutrophils: implications for inflammatory
diseases. Blood, 105: 830-837.
407. Schmidt WA and Blockmans D (2005) : Use of ultrasonography and
positron emission tomography in the diagnosis and assessment of large-
vessel vasculitis. Curr Opin Rheumatol. Jan ;17(1): 9-15.
408. Schur PH, (1995) : Genetics of systemic lupus erythematosus.
Lupus; 4: 425–37.
409. Schwarz BA and Bhandoola A (2006) : Trafficking from the bone
marrow to the thymus: a prerequisite for thymopoiesis. Immunol Rev
209:47.
410. Scott DGI, Bacon E, and Elliot PJ (1982) : Systemic vasculitis in a
district general hospital 1972-1980: Clinical and laboratory features,
classification and prognosis in 80 cases. Q J Med; 203: 292-311.
411. Sebbag M, Simon M, Vincent C, Masson-Bessière C, Girbal E,
Durieux JJ and et al., (1995) : The antiperinuclear factor and the so-
called antikeratin antibodies are the same rheumatoid arthritis-specific
autoantibodies. J Clin Invest. 95: 2672–9.
412. Semana G et al., (1999) : J. Autoimmun. 12: 259.
413. Seo P and Stone J (2004) : The Antineutrophil Cytoplasmic
Antibody-Associated Vasculitides. Am J Med; 117: 39-50.
414. Sergio Generini, (2009) : Anti-hnRNP and other autoantibodies in
systemic sclerosis with joint involvement; Rheumatology Advanced
Access. May 29.
415. Sharpe A.H. and Freeman G.J. (2002) : Nat. Rev. Immunol. 2:116.
416. Shaun Ruddy, Bennett R.M, Edward D, Harris Jr, Clement B,
Sledge, Gary S. Firestein, John S. Sergent, Mark C. Genovese and
Ralph C., Budd W. B. (2007) : "Autoantibodies are present in low
titers in the general population "in Textbook of Rheumatology, 8 th
Edition, EditorsSaunders Co., Philadelphia.
417. Shennan and Douglas H (2006) : Evolution and the Spiral of
Technology. Trafford Publishing. http://en.wikipedia.org/wiki/HLA
418. Shepherd B et al., (2005) : "Inflammatory Bowel Disease:
Diagnostic and Treatment Options". Hospital Physician: 11–19.
419. Sherwood L, (2010) : Human physiology; from cells to systems. 7th
ed. Australia ; United States: Cole Cengage Learning;
420. Shevach E.M, (2002) : Nat. Rev. Immunol. 2:389.
421. Shihoko Okazaki, (2009) : "Autoantibody (Ab) against caspase-3, an
executioner of apoptosis, in patients with systemic sclerosis (SSc)"
(Springer Link) Rheumatology International. July 28.
422. Shiloh MU, MacMicking JD, Nicholson S, Brause JE, Potter S,
Marino M, Fang F, Dinauer M, Martinon F, Pétrilli V, Mayor A,
Tardivel A and Tschopp J. (2006) : Innate recognition to differentiate
between self and non-self Ann. Rev;118 (4): 789–98.
423. Shin YS, Choi JH, Nahm DH, et al., (2005) : Rheumatoid factor is a
marker of disease severity in Korean rheumatoid arthritis. Yonsei Med
J. Aug 31;46 (4): 464-70.
424. Shinkai Y, et al., (1993) : Science 259:822.
425. Shoenfeld Y and Aron-Maor A (2000) : "Vaccination and
autoimmunity - Vaccinosis: A dangerous liaison?" J Autoimun; 14: 1-
10.
426. Silverstein AM, (2003) : "Cellular versus humoral immunology : a
century-long dispute". Nat. Immunol. 4 (5): 425–8.
427. Silverstein AM, (2004) : "Labeled antigens and antibodies: the
evolution of magic markers and magic bullets". Nat. Immunol. 5 (12):
1211–7.
428. Sim RB and Tsiftsoglou SA (2004) : "Proteases of the complement
system". Biochemical Society Transactions 32 (Pt 1): 21–7.
429. SL Nihtyanova, (2010) : Autoantibodies as predictive tools in
systemic sclerosis; Nat Rev Rheumatol. Feb.
430. Smith JA, Märker-Hermann E, Colbert RA (2006) : Pathogenesis
of ankylosing spondylitis; current concepts. Best Pract Res Clin
Rheumatol 20: 571-591.
431. Sokol C.L., Barton G.M., Farr A.G. and Medzhitov R. (2008) : "A
mechanism for the initiation of allergen-induced T helper type 2
responses". Nat Immunol 9 (3): 310–318.
432. Soler-Palacn P, Margareto C, Llobet P, et al., (2007) : "Chronic
granulomatous disease in pediatric patients: 25 years of experience".
Allergol Immunopathol (Madr) 35 (3): 83–9.
433. Spencer-Green G, Alter D, Welch HG (1997) : Test performance in
systemic sclerosis: anti-centromere and anti-Scl-70 antibodies. Am J
Med. Sep;103(3): 242-8.
434. Sperling A.I. et al., (1996) : J. Immunol. 157: 3909.
435. Sridhar Rao PN, (2006) : www.microrao.com
436. Sriskandan S, Faulkner L and Hopkins P (2007) : Streptococcus
pyogenes: Insight into the function of the streptococcal superantigens".
Int. J. Biochem. Cell Biol. 39 (1): 12–9.
437. Stacy P Ardoin and David S Pisetsky (2008) : Developments in the
scientific understanding of lupus Arthritis Research and Therapy,
10:218.
438. Stauffer Y, Marguerat S, Meylan F, et al., (2001) : "Interferon-
alpha-induced endogenous superantigen. a model linking environment
and autoimm- unity". Immunity October, 15 (4): 591–601.
439. Stavnezer J and Amemiya CT (2004) : "Evolution of isotype
switching". Semin. Immunol. 16 (4): 257–75.
440. Stefanova I., Dorfman J. R. and Germain R. N. (2002)
:autoimmune disorder; " failure of self-recognition promotes the
sensitivity of naive T lymphocytes". Nature 420 (6914): 429–434.
441. Steinman R.M. and M.C. Nussensweig (2002) : Proc. Natl. Acad.
Sci. USA 99:351.
442. Steven GE Marsh, (2010) : hla.alleles.org
443. Stevens FJ, Solomon A and Schiffer M (1991) : "Bence Jones
proteins: a powerful tool for the fundamental study of protein chemistry
and pathophysiology". Biochemistry 30 (28): 6803–5.
444. Stiles BG and Krakauer (2005) : "Staphylococcal Enterotoxins: a
Purging Experience in Review, Part I". Clinical Microbiology
Newsletter 27: 23.
445. Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T,
Morinobu A, Kumagai S (2010) : "Impact of smoking as a risk factor
for developing rheumatoid arthritis: a meta-analysis of observational
studies". Ann Rheum Dis. Jan 69 (1): 70–81.
446. Susan D Moffatt-Bruce, (2008) : Induction of Tolerance
http://emedicine. medscape.com/article/430449/overview
447. Susin SA, Lorenzo HK, Zamzami N (1999) : "Molecular
characterization of mitochondrial apoptosis-inducing factor". Nature
February; 397 (6718): 441–6.
448. Syngle A, Vohra K, Sharma A, Kaur L. (2010) : Endothelial
dysfunction in ankylosing spondylitis improves after tumor necrosis
factor-alpha blockade.Clin Rheumatol. Jul;29(7):763-70. Mar 5.
449. Syuto T, Shimizu A, Takeuchi Y, et al., (2009) : "Association of
antiphosphatidylserine/prothrombin antibodies with neuropsych iatric
systemic lupus erythematosus and lupus nephritis" Clin. Rheumatol.
February 28 (7): 841–5.
450. Tai YJ, Chong AH, Williams RA, Cumming S, Kelly RI. (2006) :
Retrospective analysis of adult patients with cutaneous leukocytoc-
lastic vasculitis. Australas J Dermatol. May ;47(2): 92-6.
451. Takahashi T. et al., (2000) : J. Exp. Med. 192:303.
452. Tannock IF and Hill RP et al., (2005) : The Basic Science of
Oncology 4th ed. McGraw-Hill.
453. Terrier B, (2008) : American Journal of Respiratory and Critical Care
Medicine Vol 177. pp. 1128-1134,.
454. Terrier B, Saadoun D, Sène D, Ghillani P, Amoura Z, Deray G, et
al., (2009) : useful markers of disease activity in antineutrophil
cytoplasmic antibody-associated vasculitides. Ann Rheum Dis.Oct;
68(10) : 1564-71.
455. Tervaert JWC, Popa ER and Bos NA (1999) : The role of
superantigens in vasculitis. Curr Op Rheum;11: 24-33.
456. Thompson C.B. and Shevach E.M. et al., (2003) : Proc. Natl. Acad.
Sci. USA 86:1333.
457. Tian B, Nowak DE and Brasier AR. (2005) : A TNF-induced gene
expression program under oscillatory NF-kappaB control. BMC
Genomics. Sep 28;6:137.
458. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T,
et al., (2003) : An intronic SNP in a RUNX1 binding site of SLC22A4,
encoding an organic cation transporter, is associated with rheumatoid
arthritis. Nat Genet; 35: 341–8.
459. Tolar P, Sohn HW and Pierce SK (2008) : "Viewing the antigen-
induced initiation of B-cell activation in living cells". Immunol. Rev.
221: 64–76.
460. Tomasi TB, (1992) : "The discovery of secretory IgA and the mucosal
immune system". Immunol. Today 13 (10): 416–8.
461. Torsteinsdottir I, Arvidson NG, Hallgren R, Hakansson L (1999)
: Enhanced expression of integrins and CD66b on peripheral blood
neutrophils and eosinophils patients with rheumatoid arthritis, and the
effect of glucocorticoids. Scand J Immunol , 50:433-439.
462. Townes JM, Deodhar AA, Laine ES, et al., (2008) : Reactive
arthritis following culture-confirmed infections with bacterial
genitourinary or enteric pathogens in Minnesota and Oregon: a
population-based study. Ann Rheum Dis. Dec;67(12): 1689-96.
463. Travis MA et al., (2007) : Loss of integrin alpha (v)beta8 on dendritic
cells causes autoimmunity and colitis in mice. Nature. Sep
20;449(7160):361-5. Aug 12.
464. Trung PH, Prieur AM, and Griscelli C (1980) : Neutrophil
chemotaxis in juvenile chronic arthritis. Ann Rheum Dis , 39: 481-484.
465. Uz E, Loubiere LS, Gadi VK, et al., (2008) : Skewed X-
chromosome inactivation in scleroderma". Clin Rev Allergy Immunol,
June 34 (3): 352–5.
466. V. Geraci SA, (2007) : "Rheumatoid arthritis: diagnosis and
management". Am. J. Med. 120 (11): 936–9.
467. Van der Woude FJ, Rasmussen N, Lobatto S et al., (1985) :
Autoantibodies against neutrophils and monocytes: tool for diagnosis
and marker of disease activity in Wegener's granulomatosis. Lancet; 1
(8426): 425-9.
468. Van Epps HL, (2006) : "Michael Heidelberger and the
demystification of antibodies". J. Exp. Med. 203 (1): 5.
469. Van Gaalen F, Ioan-Facsinay A, Huizinga TW, and Toes RE
(2005) : "The devil in the details: the emerging role of anticitrulline
autoimmunity in rheumatoid arthritis". J. Immunol. 175 (9): 5575–80.
470. Van Nieuwenhuijze, A.E., T. van Lopik, R.J. Smeenk, and L.A.
Aarden (2003) : Time between onset of apoptosis and release of
nucleosomes from apoptotic cells: putative implications for systemic
lupus erythematosus. Ann. Rheum. Dis. 62:10–14.
471. Vance R.E, (2000) : Cutting edge commentary: A Copernican
Revolution? Doubts about the danger theory. Journal of Immunology
165:1725-1728.
472. Vandal OH, Pierini LM, Schnappinger D, Nathan CF, and Ehrt S
(2008) : "phagosome subsequently fuses with lysosome to form a
phagolysosome". Nat Med. 14 (8): 849–854.
473. Vedove CD, Del Giglio M, Schena D and Girolomoni G (2009):
Autoantibodies and Drug-induced lupus erythematosus. Arch Dermatol
Res. Jan; 301(1): 99-105.
474. Vereecke L, Beyaert R, van Loo G. (2009) : The ubiquitin-editing
enzyme A20 (TNFAIP3) is a central regulator of immunopathology
Trends Immunol. Aug;30 (8): 383-91. Epub Jul 28. Review.
475. Verrecchia F, Laboureau J, Verola O, et al., (2007) : Skin
involvement in scleroderma-where histological and clinical scores
meet. Rheumatology (Oxford). May ;46(5): 833-41.
476. Victor FC and Gottlieb AB (2002) : TNF-alpha and apoptosis:
implications for the pathogenesis and treatment of psoriasis. J Drugs
Dermatol; 1:264–75.
477. Vilma Urbonaviciute, Barbara G. Fürnrohr, Silke Meister, Luis
Munoz, Petra Heyder, Francesco De Marchis, Marco E. Bianchi,
Carsten Kirschning, Hermann Wagner, Angelo A. Manfredi,
Joachim R. Kalden, Georg Schett,Patrizia Rovere-Querini, Martin
Herrmann, and Reinhard E. Voll (2008) : Induction of
inflammatory and immune responses by HMGB1–nucleosome
complexes: implications for the pathogenesis of SLE Dec. 8, JEM vol.
205no. 133007-3018.
478. Vittecoq O, Pouplin S, Krzanowska K, et al., (2003) : Rheumatoid
factor is the strongest predictor of radiological progression of
rheumatoid arthritis in a three-year prospective study in community-
recruited patients. Rheumatology (Oxford) Aug; 42 (8): 939-46.
479. Vojdani A, (2008) : Antibodies as predictors of complex autoimmune
diseases.Int J Immunopathol Pharmacol. Jun; 21 (2): 267-78.
480. Wajant H (2002) : "The Fas signaling pathway: more than a
paradigm". Science 296 (5573): 1635–6.
481. Wajant, H. (2009) : "Connection Map for Fas Signaling Pathway".
Science. http://stke.sciencemag.org/cgi/cm/CMP_7966.
482. Walker L.S.K. and A.K. Abbas (2002) : Nat. Rev. Immunol. 2:11.
483. Walker, L.S.K. andA.K. Abbas (2002) : illustration has been
adapted from Nat. Rev. Immunol. 2:11
484. Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox
L, Khan DA et al., (2008) : The diagnosis and management of rhinitis:
an updated practice parameter. J Allergy Clin Immunol. Aug: 122(2).
485. Walport MJ, Davies KA, and Botto M (2007) : C1q and systemic
lupus Erythematosus; Nat. Immunol.6: 487–496.
486. Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes
W, et al., (2007) : Development and validation of a consensus
methodology for the classification of the ANCA-associated vasculitides
and polyarteritis nodosa for epidemiological studies. Ann Rheum
Dis. Feb;66(2): 222-7.
487. Weinman EJ, (2001) : New functions for the NHERF family of
proteins. J Clin Invest;108: 185–6.
488. Weintraub R.C. et al., (2000) : J. Exp. Med. 191:1443.
489. Wilson D, (2006) : Rheumatoid factors in patients with rheumatoid
arthritis. Can Fam Physician. Feb; 52: 180-1.
490. Wintrobe and Maxwell Myer (2004) : Wintrobe's clinical
hematology. John G. Greer, John Foerster, John N Lukens, George M
Rodgers, Frixos Paraskevas (11 ed.). Hagerstown, MD: Lippincott
Williams & Wilkins. pp. 453–456.
491. Wisnieski JJ, (2000) : Urticarial vasculitis. Curr Op Rheum; 12: 24-
31.
492. Witort-Serraglini E, Del Rosso M, Lotti TM, et al., (1999):
Endothelial injuries in vasculitides. Clin in Derm;17:587-90.
493. Wochenschr, (2008) : Autoantibodies in systemic sclerosis
(scleroderma); clues for clinical evaluation, prognosis and
pathogenesis. Wien Med Wochenschr. Jan;158(1-2):19-28.
494. Woof J and Burton D (2004) : "Human antibody-Fc receptor
interactions illuminated by crystal structures". Nat Rev Immunol 4 (2):
89–99.
495. Wu IB and Schwartz RA (2008) : Reiter's syndrome: the classic triad
and more. J Am Acad Dermatol. Jul ;59(1):113-21.
496. Yamaguchi A, Tsuchiya N, Mitsui H, Shiota M, Ogawa A,
Tokunaga K, et al., (1995) : Association of HLA-B39 with HLA-B27-
negative ankylosing spondylitis and pauciarticular juvenile rheumatoid
arthritis in Japanese patients. Evidence for a role of the peptide-
anchoring B pocket. Arthritis Rheum 38:1672-1677.
497. Yamaguchi M, Nadler S, Lee JW, Deeg HJ (1999) : "Induction of
negative regulators of haematopoiesis in human bone marrow cells by
HLA-DR cross-linking". Transpl. Immunol. September 7 (3): 159–68.
498. Yang Xiang, Taichi Sekine , Hiroshi Nakamura, Shinobu Imajoh-
Ohmi, Hiroyuki Fukuda, Kazuo Yudoh, Kayo Masuko-Hongo,
Kusuki Nishioka and Tomohiro Kato (2006) : The Journal of
Immunology, 176: 3196-3204.
499. Yasuhiko Hirabayashi, Yumiko Oka, Tomoko Ikeda, Hiroshi
Fujii, Tomonori Ishii, Takeshi Sasaki, and Hideo Harigae (2010) :
The Journal of Immunology, 184, 3276 -3283.
500. Yoshida H, Pommier Y, and Ueda T (2006) : Endonuclease
activation and chromosomal DNA fragmentation during apoptosis in
leukemia cells. Int. J. Hematol. 84:367–376.
501. Young BJ, Mallya RK, Leslie RD, Clark CJ and Hamblin TJ
(1979) : "Anti-keratin antibodies in rheumatoid arthritis". Br Med J 2
(6182): 97–9.
502. Zaccone P, Fehervari Z, Phillips JM, Dunne DW and Cooke A
(2006) : Parasitic worms and inflammatory diseases". Parasite
Immunol. 28 (10): 515–23.
503. Zen K and Parkos CA (2003) : "Leukocyte - epithelial interactions".
Current Opinion in Cell Biology 15 (5): 557–64.
504. Zimmermann-Gorsk (2008): Polymyalgia rheumatica: clinical
picture and principles of treatment. Pol Arch Med Wewn.; 118: 377-
380.
505. Zuber JP and Spertini F (2006) : Rheumatology, Immunological
basis of systemic sclerosis; Volume 45, Supplement 1, October, pp.
iii23-iii25(3).
